This is one of the strongest arguments for staying at or near the 100 mcg per injection saturation dose rather than escalating higher
Additionally, musculoskeletal complaints are prevalent in the general populationparticularly among individuals with obesity, diabetes, and advancing agemaking it challenging to determine whether such symptoms are medication-related
Less commonly, however, it may also cause severe nausea and vomiting , arthralgia , restless leg syndrome , skin color changes , and (in contradiction to the theory weve discussed) transient blood pressure increases .21 The likelihood and severity of these side effects may be dose- and duration-dependent: the stronger your dose and the longer you use the drug, the higher your risk of experiencing serious adverse events
Current trials include participants with obesity, both with and without related conditions such as osteoarthritis or sleep apnoea
Incorporating a well-balanced GLP-1 meal plan is essential for maximizing the effects of glucagon-like peptide-1 (GLP-1) medications